440 related articles for article (PubMed ID: 21619050)
1. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.
Li J; Poi MJ; Tsai MD
Biochemistry; 2011 Jun; 50(25):5566-82. PubMed ID: 21619050
[TBL] [Abstract][Full Text] [Related]
2. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of a hyperstable p16INK4a that restores Cdk4 binding activity when combined with oncogenic mutations.
Cammett TJ; Luo L; Peng ZY
J Mol Biol; 2003 Mar; 327(1):285-97. PubMed ID: 12614625
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16 INK4A.
Li J; Qin D; Knobloch TJ; Tsai MD; Weghorst CM; Melvin WS; Muscarella P
Biochem Biophys Res Commun; 2003 May; 304(2):241-7. PubMed ID: 12711305
[TBL] [Abstract][Full Text] [Related]
5. Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.
Yarbrough WG; Buckmire RA; Bessho M; Liu ET
J Natl Cancer Inst; 1999 Sep; 91(18):1569-74. PubMed ID: 10491434
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications.
Jiao Y; Feng Y; Wang X
Biochemistry (Mosc); 2018 Nov; 83(11):1289-1298. PubMed ID: 30482142
[TBL] [Abstract][Full Text] [Related]
7. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
8. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
9. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
[TBL] [Abstract][Full Text] [Related]
10. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
Ming Z; Lim SY; Rizos H
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
[TBL] [Abstract][Full Text] [Related]
11. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.
Zhao R; Choi BY; Lee MH; Bode AM; Dong Z
EBioMedicine; 2016 Jun; 8():30-39. PubMed ID: 27428416
[TBL] [Abstract][Full Text] [Related]
12. GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.
Sun P; Nallar SC; Raha A; Kalakonda S; Velalar CN; Reddy SP; Kalvakolanu DV
J Biol Chem; 2010 Sep; 285(36):27545-52. PubMed ID: 20522552
[TBL] [Abstract][Full Text] [Related]
13. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
Kriegl L; Neumann J; Vieth M; Greten FR; Reu S; Jung A; Kirchner T
Mod Pathol; 2011 Jul; 24(7):1015-22. PubMed ID: 21423154
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
[TBL] [Abstract][Full Text] [Related]
15. The molecular balancing act of p16(INK4a) in cancer and aging.
LaPak KM; Burd CE
Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
[TBL] [Abstract][Full Text] [Related]
16. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
[TBL] [Abstract][Full Text] [Related]
17. Ageing as developmental decay: insights from p16(INK4a.).
Martin N; Beach D; Gil J
Trends Mol Med; 2014 Dec; 20(12):667-74. PubMed ID: 25277993
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.
Arap W; Knudsen E; Sewell DA; Sidransky D; Wang JY; Huang HJ; Cavenee WK
Oncogene; 1997 Oct; 15(17):2013-20. PubMed ID: 9366518
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
20. Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16
Göbl C; Morris VK; van Dam L; Visscher M; Polderman PE; Hartlmüller C; de Ruiter H; Hora M; Liesinger L; Birner-Gruenberger R; Vos HR; Reif B; Madl T; Dansen TB
Redox Biol; 2020 Jan; 28():101316. PubMed ID: 31539802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
